News
An app that links to Apple Watch technology has been granted FDA approval to help monitor some motor symptoms experienced by people with Parkinson's.
We're calling on the Parkinson's community to take part in 5 important clinical studies that are currently at risk of closure.
Biotech company, NRG Therapeutics, has today announced an Innovate UK award to continue its drug development project, supported by the Parkinson's Virtual Biotech, into life-changing new treatments.
Our chair, Gary Shaughnessy, shares updates from our recent meeting of trustees, from promising new research initiatives to a promise to abseil down a building in Northern Ireland.
Research led by Cambridge University and part funded by Parkinson's UK shows that a form of brain scan could help identify those at risk of specific Parkinson's symptoms.
Sport Parkinson's have raised over £73,000 to help people with Parkinson's get and stay active.
Juliet, who's currently Director of Policy and Partnerships at the Health Research Authority, will be joining the charity this summer.
A trial of a new miniaturised deep brain stimulation (DBS) device, being carried out at Southmead Hospital in Bristol, aims to make improvements to existing surgery.
Over 170 buildings across the UK lit up blue to encourage people to talk about Parkinson's.
A pioneering partnership between global biopharmaceutical company UCB, Parkinson's UK and the Parkinson's Foundation in the US is laying the foundations for people with Parkinson's to feed into the drug development pipeline.